ArcBest [ARCB] vs Rxo [RXO] Detailed Stock Comparison

ArcBest Corporation

NASDAQ
Loading...

Rxo Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: ArcBest Corporation wins in 13 metrics, Rxo Inc. wins in 6 metrics, with 0 ties. ArcBest Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric ArcBest Corporation Rxo Inc. Better
P/E Ratio (TTM) 47.16 645.33 ArcBest Corporation
Price-to-Book Ratio 2.13 2.04 Rxo Inc.
Debt-to-Equity Ratio 35.86 43.48 ArcBest Corporation
PEG Ratio -0.37 5.16 Rxo Inc.
EV/EBITDA 11.85 34.81 ArcBest Corporation
Profit Margin (TTM) 1.50% -1.74% ArcBest Corporation
Operating Margin (TTM) 0.42% -0.61% ArcBest Corporation
EBITDA Margin (TTM) 0.42% N/A N/A
Return on Equity 4.61% -6.34% ArcBest Corporation
Return on Assets (TTM) 2.15% -0.13% ArcBest Corporation
Free Cash Flow (TTM) $100.79M $-8.00M ArcBest Corporation
Dividend Yield 0.60% N/A N/A
1-Year Return 154.10% 84.69% ArcBest Corporation
Price-to-Sales Ratio (TTM) 0.69 0.55 Rxo Inc.
Enterprise Value $3.01B $3.79B Rxo Inc.
EV/Revenue Ratio 0.75 0.66 Rxo Inc.
Gross Profit Margin (TTM) 5.09% 13.00% Rxo Inc.
Revenue per Share (TTM) $176 $34 ArcBest Corporation
Earnings per Share (Diluted) $2.62 $-0.59 ArcBest Corporation
Beta (Stock Volatility) 1.43 1.53 ArcBest Corporation
Short % of Float 7.88% 24.27% ArcBest Corporation

ArcBest Corporation vs Rxo Inc. Stock Performance Analysis

Loading Price Chart...

ARCB
RXO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
ArcBest Corporation-5.17%-1.28%33.73%95.06%112.59%112.65%
Rxo Inc.-2.26%-1.28%48.26%131.69%84.73%115.81%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
ArcBest Corporation154.10%96.12%219.56%943.67%687.26%311.12%
Rxo Inc.84.69%26.85%31.86%31.86%31.86%31.86%

Performance & Financial Health Analysis: ArcBest Corporation vs Rxo Inc.

MetricARCBRXO
Market Information
Market Cap i$2.73B$3.18B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i253,8311,942,255
90 Day Avg. Volume i289,0571,877,215
Last Close$164.10$27.71
52 Week Range$59.43 - $176.69$10.43 - $29.86
% from 52W High-7.13%-7.20%
All-Time High$176.69 (Jun 12, 2026)$32.82 (Jul 29, 2024)
% from All-Time High-7.13%-15.57%
Growth Metrics
Quarterly Revenue Growth-0.03%-0.12%
Quarterly Earnings Growth-0.03%-0.12%
Financial Health
Profit Margin (TTM) i0.02%-0.02%
Operating Margin (TTM) i0.00%-0.01%
Return on Equity (TTM) i0.05%-0.06%
Debt to Equity (MRQ) i35.8643.48
Cash & Liquidity
Book Value per Share (MRQ)$57.98$9.39
Cash per Share (MRQ)$5.57$0.10
Operating Cash Flow (TTM) i$228.95M$51.00M
Levered Free Cash Flow (TTM) i$79.07M$42.75M
Dividends
Last 12-Month Dividend Yield i0.60%N/A
Last 12-Month Dividend i$0.60N/A

Valuation & Enterprise Metrics Analysis: ArcBest Corporation vs Rxo Inc.

MetricARCB (Apr 26, 2026)RXO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i47.16645.33
Forward P/E i16.6349.16
PEG Ratio i-0.375.16
Price to Sales (TTM) i0.690.55
Price to Book (MRQ) i2.132.04
Market Capitalization
Market Capitalization i$2.73B$3.18B
Enterprise Value i$3.01B$3.79B
Enterprise Value Metrics
Enterprise to Revenue i0.750.66
Enterprise to EBITDA i11.8534.81
Risk & Other Metrics
Beta i1.431.53
Book Value per Share (MRQ) i$57.98$9.39

Financial Statements Comparison: ArcBest Corporation vs Rxo Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricARCB (2025)RXO (2025)
Revenue/Sales i4.01B5.74B
Cost of Goods Sold i3.73B4.92B
COGS % of Revenue i93.1%85.6%
Gross Profit i275.26M825.00M
Gross Margin i6.9%14.4%
Research & Development iN/AN/A
Operating Income (EBIT) i99.70M-7.00M
Operating Margin i2.5%-0.1%
EBITDA i275.18M108.00M
EBITDA Margin i6.9%1.9%
Pre-Tax Income i83.10M-115.00M
Pre-Tax Income % of Revenue i2.1%-2.0%
Income Tax i23.00M-15.00M
Income Tax % of Revenue i0.6%-0.3%
Net Income (Profit) i60.10M-100.00M
Profit Margin i1.5%-1.7%

Balance Sheet & Liquidity Metrics

MetricARCB (2025)RXO (2025)
Cash & Equivalents i102.03M17.00M
Total Current Assets i626.06M1.32B
Total Current Assets % of Revenue i15.6%22.9%
Total Current Liabilities i656.89M1.04B
Total Current Liabilities % of Revenue i16.4%18.1%
Long-Term Debt i340.31M578.00M
Long-Term Debt % of Revenue i8.5%10.1%
Total Shareholders Equity i1.30B1.54B
Retained Earnings i1.48B-384.00M
Retained Earnings % of Revenue i37.0%-6.7%
Property, Plant & Equipment i1.42B238.00M

Cash Flow Statement Comparison

MetricARCB (2025)RXO (2025)
Operating Cash Flow i230.48M33.00M
Operating Cash Flow % of Revenue i5.7%0.6%
Capital Expenditures i-80.31M-57.00M
Free Cash Flow i100.79M-8.00M
FCF Margin i2.5%-0.1%
Debt Repayment i-108.13M-535.00M
Common Stock Repurchase i-75.57M0

Short Interest & Institutional Ownership Analysis

MetricARCBRXO
Shares Short i1.27M13.95M
Short Ratio i4.197.29
Short % of Float i7.88%24.27%
Shares Outstanding i22.35M164.16M
Float Shares i21.95M125.56M
% Held by Insiders i1.38%0.86%
% Held by Institutions i109.75%107.88%
% Held by Public i-11.13%-8.74%

Dividend Analysis & Yield Comparison: ArcBest Corporation vs Rxo Inc.

MetricARCBRXO
Last 12-Month Dividend i$0.60N/A
Last 12-Month Dividend Yield i0.60%N/A
3-Year Avg Annual Dividend i$0.52N/A
3-Year Avg Dividend Yield i0.13%N/A
3-Year Total Dividends i$1.56N/A
Ex-Dividend DateFeb 10, 2026N/A